Active Ingredient (In Each Tablet)
Caffeine 200 mg
The following Structured Product Label (SPL) was submitted to the FDA by L.n.k. International, Inc. for the product Alert (NDC 50844-226). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, do not use, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Caffeine 200 mg
Alertness aid
helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness
For occasional use only
Caffeine warning: The recommended dose of this product contains about as much caffeine as a cup of coffee. Limit the use of caffeine-containing medications, foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heartbeat.
fatigue or drowsiness persists or continues to recur.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
corn starch, D&C yellow #10 aluminum lake, dextrose, dicalcium phosphate, FD&C yellow #6 aluminum lake, magnesium stearate, microcrystalline cellulose, silica gel
1-800-426-9391
QUALITY
PLUS
NDC 50844-226-21
*Compare to active ingredient
in VIVARIN®
ALERT TABLETS
Caffeine 200 mg
ALERTNESS AID
Equal to about a cup of coffee
16 Tablets
ACTUAL SIZE
TAMPER EVIDENT: DO NOT USE IF CARTON IS OPENED OR IF BLISTER UNIT IS TORN,
BROKEN OR SHOWS ANY SIGNS OF TAMPERING
*This product is not manufactured or distributed by Meda
Consumer Healthcare, owner of the registered trademark Vivarin®.
50844 REV0412A22621
Distributed by LNK INTERNATIONAL, INC.
60 Arkay Drive, Hauppauge, NY 11788
USA
* Please review the disclaimer below.